GlobeNewswire Inc.··NaBelite Bio to Detail Q1 2026 Results, Tinlarebant Trial Progress on May 20
Belite Bio will host webcast May 20, 2026 to discuss Q1 financial results and provide updates on tinlarebant trials for retinal diseases.
BLTEPhase 3 trialwebcast